Top 5 This Week

Related Posts

FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients


Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles